Literature DB >> 16784238

Evidence for preorganization of the glmS ribozyme ligand binding pocket.

Ken J Hampel1, Melissa M Tinsley.   

Abstract

We have examined the tertiary structure of the ligand-activated glmS ribozyme by a combination of methods with the aim of evaluating the magnitude of RNA conformational change induced by binding of the cofactor, glucosamine 6-phosphate (GlcN6P). Hydroxyl radical footprinting of a trans-acting ribozyme complex identifies several sites of solvent protection upon incubation of the RNA in Mg(2+)-containing solutions, providing initial evidence of the tertiary fold of the ribozyme. Under these folding conditions and at GlcN6P concentrations that saturate the ligand-induced cleavage reaction, we do not observe changes to this pattern. Cross-linking with short-wave UV light of the complex yielded similar overall results. In addition, ribozyme-substrate complexes cross-linked in the absence of GlcN6P could be gel purified and then activated in the presence of ligand. One of these active cross-linked species links the base immediately 3' of the cleavage site to a highly conserved region of the ribozyme core and could be catalytically activated by ligand. Combined with recent studies that argue that GlcN6P acts as a coenzyme in the reaction, our data point to a riboswitch mechanism in which ligand binds to a prefolded active site pocket and assists in catalysis via a direct participation in the reaction chemistry, the local influence on the geometry of the active site constituents, or a combination of both mechanisms. This mode of action is different from that observed for other riboswitches characterized to date, which act by inducing secondary and tertiary structure changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784238     DOI: 10.1021/bi060337z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Protonation states of the key active site residues and structural dynamics of the glmS riboswitch as revealed by molecular dynamics.

Authors:  Pavel Banás; Nils G Walter; Jirí Sponer; Michal Otyepka
Journal:  J Phys Chem B       Date:  2010-07-08       Impact factor: 2.991

2.  Use of a coenzyme by the glmS ribozyme-riboswitch suggests primordial expansion of RNA chemistry by small molecules.

Authors:  Adrian R Ferré-D'Amaré
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

3.  Structural transitions and thermodynamics of a glycine-dependent riboswitch from Vibrio cholerae.

Authors:  Jan Lipfert; Rhiju Das; Vincent B Chu; Madhuri Kudaravalli; Nathan Boyd; Daniel Herschlag; Sebastian Doniach
Journal:  J Mol Biol       Date:  2006-10-13       Impact factor: 5.469

Review 4.  The intricate world of riboswitches.

Authors:  Rebecca L Coppins; Kathleen B Hall; Eduardo A Groisman
Journal:  Curr Opin Microbiol       Date:  2007-03-23       Impact factor: 7.934

5.  Mechanism and distribution of glmS ribozymes.

Authors:  Phillip J McCown; Wade C Winkler; Ronald R Breaker
Journal:  Methods Mol Biol       Date:  2012

6.  Deciphering the role of glucosamine-6-phosphate in the riboswitch action of glmS ribozyme.

Authors:  Yao Xin; Donald Hamelberg
Journal:  RNA       Date:  2010-10-22       Impact factor: 4.942

Review 7.  RNA catalysis: ribozymes, ribosomes, and riboswitches.

Authors:  Scott A Strobel; Jesse C Cochrane
Journal:  Curr Opin Chem Biol       Date:  2007-11-05       Impact factor: 8.822

8.  Improved native affinity purification of RNA.

Authors:  Robert T Batey; Jeffrey S Kieft
Journal:  RNA       Date:  2007-06-04       Impact factor: 4.942

9.  An in vitro evolved glmS ribozyme has the wild-type fold but loses coenzyme dependence.

Authors:  Matthew W L Lau; Adrian R Ferré-D'Amaré
Journal:  Nat Chem Biol       Date:  2013-10-06       Impact factor: 15.040

Review 10.  The structural and functional diversity of metabolite-binding riboswitches.

Authors:  Adam Roth; Ronald R Breaker
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.